RAYSOLMI Trademark
Trademark Overview
On Thursday, December 7, 2023, a trademark application was filed for RAYSOLMI with the United States Patent and Trademark Office. The USPTO has given the RAYSOLMI trademark a serial number of 98302895. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, August 28, 2025. This trademark is owned by Eli Lilly and Company. The RAYSOLMI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative co...
General Information
| Serial Number | 98302895 |
| Word Mark | RAYSOLMI |
| Filing Date | Thursday, December 7, 2023 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Thursday, August 28, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 20, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 7, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Eli Lilly and Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285
US |
| Party Name | Eli Lilly and Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Indianapolis, IN 46285
US |
Trademark Events
| Event Date | Event Description |
| Thursday, December 7, 2023 | NEW APPLICATION ENTERED |
| Monday, March 4, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, July 8, 2024 | ASSIGNED TO EXAMINER |
| Monday, July 15, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 31, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 20, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 20, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 15, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, February 27, 2025 | SOU TEAS EXTENSION RECEIVED |
| Thursday, February 27, 2025 | SOU EXTENSION 1 FILED |
| Thursday, February 27, 2025 | SOU EXTENSION 1 GRANTED |
| Thursday, February 27, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, August 28, 2025 | SOU TEAS EXTENSION RECEIVED |
| Thursday, August 28, 2025 | SOU EXTENSION 2 FILED |
| Thursday, August 28, 2025 | SOU EXTENSION 2 GRANTED |
| Monday, September 15, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, March 20, 2026 | SOU TEAS EXTENSION RECEIVED |
| Thursday, May 21, 2026 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, May 21, 2026 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, May 21, 2026 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
